Precipio, Inc.(PRPO)Earnings, Financials & Key Ratios
PRPO•NASDAQ
$30.40
$53M mkt cap·Price updated May 7, 2026
AboutPrecipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.Show more
- Revenue$16M+5.1%
- EBITDA-$3M+57.2%
- Net Income-$4M+26.7%
- EPS (Diluted)-2.93+35.0%
- Gross Margin47.35%+19.6%
- EBITDA Margin-16.93%+59.2%
- Operating Margin-26.41%+47.3%
- Net Margin-26.87%+30.2%
- ROE-32.35%+14.9%
- ROIC-24.32%+39.7%
- Debt/Equity0.10+34.0%
- Interest Coverage-56.97+86.5%
PRPO Key Insights
Precipio, Inc. (PRPO) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 90 (top 10%)
- ✓Strong 5Y sales CAGR of 38.6%
✗Weaknesses
- ✗Shares diluted 12.9% in last year
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
PRPO Price & Volume
Precipio, Inc. (PRPO) stock price & volume — 10-year historical chart
Loading chart...
PRPO Growth Metrics
Precipio, Inc. (PRPO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-5.15%
5 Years38.55%
3 Years21.74%
TTM23.63%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM58.2%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM59.04%
Return on Capital
10 Years-90.11%
5 Years-48.2%
3 Years-45.65%
Last Year-30.46%
PRPO Peer Comparison
Precipio, Inc. (PRPO) competitors in Molecular and Genetic Diagnostics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CDNA | 1.11B | 21.44 | -53.60 | 13.79% | -1.98% | -2.61% | 0.06 | |
 PACB | 498.3M | 1.65 | -0.91 | 3.89% | -341.47% | -11.23% | 141.98 | |
 NTRA | 31.16B | 219.82 | -144.62 | 35.9% | -9.03% | -15.28% | 0.13 | |
 EXAS | 20.02B | 104.91 | -95.37 | 17.69% | -6.4% | -8.66% | 1.05 | |
 VCYT | 3.25B | 40.76 | 49.71 | 16.01% | 16.25% | 6.86% | 0.03 | |
 FLGT | 449.48M | 15.11 | -7.67 | 13.83% | -18.75% | -5.42% | 0.00 | |
 CERS | 522.96M | 2.61 | -31.83 | 14.35% | -4.41% | -15.18% | 1.49 | |
 LH | 21.24B | 258.04 | 24.67 | 7.25% | 6.66% | 10.89% | 0.83 |
Compare PRPO vs Peers
Precipio, Inc. (PRPO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
PRPO Income Statement
Precipio, Inc. (PRPO) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 1.56M | 1.72M | 2.86M | 3.13M | 6.09M | 8.85M | 9.41M | 15.2M | 15.96M | 21.52M |
| Revenue Growth % | -5.81% | 10.66% | 66.22% | 9.18% | 94.82% | 45.26% | 6.36% | 61.46% | 5.05% | 23.63% |
| Cost of Goods Sold | 1.76M | 1.43M | 2.64M | 2.91M | 4.94M | 6.46M | 6.9M | 9.18M | 8.41M | 11.3M |
| COGS % of Revenue | 113.17% | 83.05% | 92.14% | 93% | 81.12% | 72.97% | 73.33% | 60.4% | 52.65% | - |
| Gross Profit | -205K▲ 0% | 292K▲ 242.4% | 225K▼ 22.9% | 219K▼ 2.7% | 1.15M▲ 425.1% | 2.39M▲ 108.0% | 2.51M▲ 4.9% | 6.02M▲ 139.8% | 7.56M▲ 25.6% | 10.22M▲ 0% |
| Gross Margin % | -13.17% | 16.95% | 7.86% | 7% | 18.88% | 27.03% | 26.67% | 39.6% | 47.35% | 47.48% |
| Gross Profit Growth % | 28.57% | 242.44% | -22.95% | -2.67% | 425.11% | 108% | 4.93% | 139.76% | 25.61% | - |
| Operating Expenses | 7.61M | 6.49M | 9.45M | 11.21M | 10.3M | 12.01M | 15.31M | 13.64M | 11.78M | 12.3M |
| OpEx % of Revenue | 489.02% | 376.55% | 330.03% | 358.59% | 169.01% | 135.66% | 162.63% | 89.74% | 73.76% | - |
| Selling, General & Admin | 6.19M | 6.49M | 9.45M | 9.62M | 10.3M | 10.71M | 13.61M | 13.64M | 11.78M | 2.19M |
| SG&A % of Revenue | 397.69% | 376.55% | 330.03% | 307.74% | 169.01% | 120.97% | 144.57% | 89.74% | 73.76% | - |
| Research & Development | 1.42M | 500K | 1.1M | 2.79M | 2.2M | 1.3M | 1.7M | 2.7M | 2.3M | 2.3M |
| R&D % of Revenue | 91.33% | 29.02% | 38.41% | 89.22% | 36.11% | 14.69% | 18.06% | 17.77% | 14.41% | - |
| Other Operating Expenses | 0 | 877K | -1.33M | -1.2M | -2.2M | 0 | 0 | -2.7M | -2.3M | 2M |
| Operating Income | -7.82M▲ 0% | -15.51M▼ 98.4% | -13.91M▲ 10.3% | -10.99M▲ 21.0% | -9.15M▲ 16.8% | -9.61M▼ 5.1% | -12.8M▼ 33.1% | -7.62M▲ 40.5% | -4.22M▲ 44.7% | -2.08M▲ 0% |
| Operating Margin % | -502.18% | -900.23% | -485.75% | -351.58% | -150.13% | -108.63% | -135.96% | -50.14% | -26.41% | -9.66% |
| Operating Income Growth % | 14.96% | -98.38% | 10.31% | 20.97% | 16.81% | -5.11% | -33.12% | 40.45% | 44.67% | - |
| EBITDA | -7.71M | -14.77M | -12.65M | -9.81M | -8M | -8.17M | -11.28M | -6.31M | -2.7M | -549K |
| EBITDA Margin % | -494.99% | -857.11% | -441.59% | -313.82% | -131.37% | -92.32% | -119.82% | -41.53% | -16.93% | -2.55% |
| EBITDA Growth % | 11.47% | -91.62% | 14.36% | 22.41% | 18.44% | -2.07% | -38.05% | 44.03% | 57.18% | 83.39% |
| D&A (Non-Cash Add-back) | 112K | 743K | 1.26M | 1.18M | 1.14M | 1.44M | 1.52M | 1.31M | 1.51M | 1.53M |
| EBIT | -1.71M | -6.2M | -9.23M | -9.4M | -9.15M | -8.5M | -12.17M | -7.62M | -4.22M | -1.17M |
| Net Interest Income | -518K | -2.32M | -1.6M | -473K | -470K | -20K | -12K | -18K | -74K | -86K |
| Interest Income | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 518K | 2.32M | 1.6M | 473K | 470K | 20K | 12K | 18K | 74K | 86K |
| Other Income/Expense | -515K | -5.18M | -2.06M | -2.32M | -1.45M | 1.1M | 619K | 1.77M | -74K | 826K |
| Pretax Income | -8.27M▲ 0% | -20.69M▼ 150.3% | -15.97M▲ 22.8% | -13.31M▲ 16.7% | -10.6M▲ 20.4% | -8.52M▲ 19.6% | -12.18M▼ 43.0% | -5.85M▲ 51.9% | -4.29M▲ 26.7% | -1.25M▲ 0% |
| Pretax Margin % | -531.09% | -1201.04% | -557.72% | -425.74% | -173.97% | -96.25% | -129.39% | -38.51% | -26.87% | -5.83% |
| Income Tax | -203K | 0 | -279K | -70K | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 2.45% | 0% | 1.75% | 0.53% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -7.62M▲ 0% | -20.69M▼ 171.7% | -15.69M▲ 24.2% | -13.24M▲ 15.6% | -10.63M▲ 19.8% | -8.55M▲ 19.5% | -12.2M▼ 42.7% | -5.85M▲ 52.0% | -4.29M▲ 26.7% | -1.25M▲ 0% |
| Net Margin % | -489.15% | -1201.04% | -547.97% | -423.5% | -174.41% | -96.62% | -129.65% | -38.51% | -26.87% | -5.83% |
| Net Income Growth % | 76.89% | -171.72% | 24.16% | 15.62% | 19.77% | 19.53% | -42.73% | 52.04% | 26.7% | 58.2% |
| Net Income (Continuing) | -2.23M | -20.69M | -15.69M | -13.24M | -10.6M | -8.52M | -12.18M | -5.85M | -4.29M | -1.25M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 27K | 40K | 65K | 0 | 0 | 0 |
| EPS (Diluted) | -580.93▲ 0% | -1338.20▼ 130.4% | -217.80▲ 83.7% | -46.51▲ 78.6% | -14.84▲ 68.1% | -8.10▲ 45.4% | -10.73▼ 32.5% | -4.51▲ 58.0% | -2.93▲ 35.0% | -0.77▲ 0% |
| EPS Growth % | 33.24% | -130.35% | 83.72% | 78.65% | 68.09% | 45.42% | -32.47% | 57.97% | 35.03% | 59.04% |
| EPS (Basic) | -580.93 | -1338.20 | -217.81 | -46.51 | -14.84 | -8.10 | -10.73 | -4.51 | -2.93 | - |
| Diluted Shares Outstanding | 48 | 15.46K | 72.06K | 284.76K | 823.85K | 1.05M | 1.14M | 1.3M | 1.47M | 1.64M |
| Basic Shares Outstanding | 48 | 15.46K | 72.06K | 284.76K | 823.85K | 1.05M | 1.14M | 1.3M | 1.47M | 1.64M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
PRPO Balance Sheet
Precipio, Inc. (PRPO) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 495K | 1.74M | 1.79M | 1.88M | 4.2M | 13.48M | 5.71M | 3.68M | 3.45M | 5.67M |
| Cash & Short-Term Investments | 110K | 421K | 381K | 848K | 2.66M | 11.67M | 3.44M | 1.5M | 1.39M | 2.31M |
| Cash Only | 110K | 421K | 381K | 848K | 2.66M | 11.67M | 3.44M | 1.5M | 1.39M | 2.31M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 388K | 730K | 690K | 574K | 874K | 697K | 1.04M | 1.3M | 799K | 1.96M |
| Days Sales Outstanding | 90.96 | 154.64 | 87.94 | 67 | 52.37 | 28.75 | 40.18 | 31.25 | 18.27 | 22.13 |
| Inventory | 24K | 161K | 197K | 184K | 350K | 564K | 708K | 384K | 724K | 788K |
| Days Inventory Outstanding | 4.97 | 41.07 | 27.25 | 23.09 | 25.85 | 31.88 | 37.44 | 15.27 | 31.44 | 27.41 |
| Other Current Assets | 13K | 100K | 300K | 72K | 0 | 0 | 0 | 195K | 0 | 618K |
| Total Non-Current Assets | 764K | 25.52M | 19.81M | 17.63M | 16.51M | 16.96M | 15.79M | 14.42M | 13.54M | 15.48M |
| Property, Plant & Equipment | 144K | 353K | 496K | 950K | 787K | 2.06M | 1.9M | 1.52M | 1.63M | 4.26M |
| Fixed Asset Turnover | 10.81x | 4.88x | 5.77x | 3.29x | 7.74x | 4.29x | 4.96x | 9.97x | 9.79x | 7.16x |
| Goodwill | 0 | 4.68M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 562K | 20.46M | 19.29M | 16.66M | 15.67M | 14.72M | 13.77M | 12.82M | 11.87M | 11.16M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 58K | 22K | 25K | 25K | 55K | 179K | 129K | 76K | 45K | 223K |
| Total Assets | 1.26M▲ 0% | 27.26M▲ 2065.2% | 21.61M▼ 20.7% | 19.51M▼ 9.7% | 20.71M▲ 6.2% | 30.44M▲ 47.0% | 21.5M▼ 29.4% | 18.1M▼ 15.8% | 17M▼ 6.1% | 21.15M▲ 0% |
| Asset Turnover | 1.24x | 0.06x | 0.13x | 0.16x | 0.29x | 0.29x | 0.44x | 0.84x | 0.94x | 1.15x |
| Asset Growth % | -73.86% | 2065.21% | -20.74% | -9.69% | 6.16% | 46.96% | -29.35% | -15.82% | -6.1% | 34.32% |
| Total Current Liabilities | 19.82M | 10.04M | 13.77M | 4.33M | 4.66M | 4.21M | 4.36M | 3.14M | 4.27M | 4.45M |
| Accounts Payable | 1.08M | 5.1M | 5.17M | 1.94M | 1.69M | 1.86M | 2.04M | 622K | 618K | 1.14M |
| Days Payables Outstanding | 224.55 | 1.3K | 714.92 | 243 | 125.04 | 105.31 | 107.99 | 24.73 | 26.83 | 30.88 |
| Short-Term Debt | 1.09M | 587K | 4.64M | 463K | 648K | 26K | 255K | 235K | 297K | 611K |
| Deferred Revenue (Current) | 170K | 66K | 49K | 35K | 6K | 18K | 119K | 110K | 232K | 1.07M |
| Other Current Liabilities | 92K | 4.1M | 3.73M | 1.39M | 0 | 0 | 491K | 1.04M | 955K | 2.43M |
| Current Ratio | 0.02x | 0.17x | 0.13x | 0.43x | 0.90x | 3.20x | 1.31x | 1.17x | 0.81x | 0.81x |
| Quick Ratio | 0.02x | 0.16x | 0.12x | 0.39x | 0.83x | 3.07x | 1.15x | 1.05x | 0.64x | 0.64x |
| Cash Conversion Cycle | -128.62 | -1.11K | -599.74 | -152.9 | -46.82 | -44.68 | -30.37 | 21.78 | 22.87 | 18.66 |
| Total Non-Current Liabilities | 785K | 4.2M | 1.72M | 1.97M | 1.9M | 1.62M | 776K | 531K | 631K | 2.95M |
| Long-Term Debt | 4.13M | 2.83M | 253K | 198K | 362K | 160K | 134K | 106K | 77K | 2.9M |
| Capital Lease Obligations | 163K | 113K | 155K | 436K | 208K | 856K | 642K | 425K | 554K | 4.35M |
| Deferred Tax Liabilities | 0 | 349K | 70K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 1.26M | 1.24M | 1.34M | 1.32M | 606K | 0 | 0 | 0 | 55K |
| Total Liabilities | 20.61M | 14.23M | 15.48M | 6.31M | 6.55M | 5.83M | 5.14M | 3.67M | 4.9M | 7.4M |
| Total Debt | 7.81M | 3.58M | 5.11M | 1.36M | 1.49M | 1.43M | 1.39M | 1.12M | 1.25M | 3.51M |
| Net Debt | 7.7M | 3.16M | 4.72M | 510K | -1.17M | -10.24M | -2.05M | -386K | -136K | 1.2M |
| Debt / Equity | - | 0.27x | 0.83x | 0.10x | 0.11x | 0.06x | 0.09x | 0.08x | 0.10x | 0.10x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | -6.39x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | -2.19x |
| Interest Coverage | -15.09x | -6.67x | -8.71x | -23.24x | -19.46x | -480.65x | -1066.42x | -423.33x | -56.97x | -13.58x |
| Total Equity | -19.35M▲ 0% | 13.03M▲ 167.3% | 6.12M▼ 53.0% | 13.21M▲ 115.7% | 14.16M▲ 7.2% | 24.6M▲ 73.7% | 16.37M▼ 33.5% | 14.43M▼ 11.8% | 12.09M▼ 16.2% | 13.75M▲ 0% |
| Equity Growth % | -50.94% | 167.31% | -52.99% | 115.66% | 7.25% | 73.73% | -33.48% | -11.84% | -16.18% | -8.08% |
| Book Value per Share | -402582.63 | 842.28 | 84.98 | 46.37 | 17.19 | 23.32 | 14.39 | 11.12 | 8.25 | 8.40 |
| Total Shareholders' Equity | -19.35M | 13.03M | 6.12M | 13.21M | 14.13M | 24.56M | 16.3M | 14.43M | 12.09M | 13.75M |
| Common Stock | 264K | 102K | 345K | 79K | 176K | 227K | 228K | 14K | 15K | 17K |
| Retained Earnings | -225.49M | -31.54M | -47.7M | -60.94M | -71.56M | -80.09M | -92.3M | -98.15M | -102.44M | -103.33M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | -555K | -653K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 27K | 40K | 65K | 0 | 0 | 0 |
PRPO Cash Flow Statement
Precipio, Inc. (PRPO) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -3.55M | -6.69M | -6.75M | -9.14M | -7.43M | -6.58M | -7.72M | -3.56M | 439K | 439K |
| Operating CF Margin % | -228% | -388.28% | -235.82% | -292.32% | -122.03% | -74.32% | -82.03% | -23.42% | 2.75% | - |
| Operating CF Growth % | 71.32% | -88.45% | -0.96% | -35.34% | 18.67% | 11.53% | -17.39% | 53.9% | 112.33% | 384.01% |
| Net Income | -8.27M | -20.69M | -15.69M | -13.24M | -10.6M | -8.52M | -12.18M | -5.85M | -4.29M | -1.25M |
| Depreciation & Amortization | 262K | 743K | 1.26M | 1.41M | 1.36M | 1.44M | 1.52M | 1.52M | 1.51M | 1.66M |
| Stock-Based Compensation | 52K | 49K | 529K | 668K | 703K | 2.03M | 3.8M | 1.74M | 1.88M | 1.7M |
| Deferred Taxes | 1.98M | 10.69M | 5.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -274K | 3.7M | 1.04M | 4.51M | 2.74M | -1.14M | -221K | -1.56M | 69K | -121K |
| Working Capital Changes | 2.7M | -1.17M | 109K | -2.49M | -1.63M | -395K | -643K | 606K | 1.27M | -1.09M |
| Change in Receivables | -33K | -495K | -541K | -850K | -1.64M | 327K | -745K | -483K | 438K | -872K |
| Change in Inventory | 26K | -46K | -36K | 13K | -166K | -214K | -144K | 324K | -340K | -198K |
| Change in Payables | 3.08M | 500K | 309K | -1.88M | -243K | 112K | 165K | -169K | -10K | 408K |
| Cash from Investing | 1.01M | -42K | -97K | -55K | -96K | -682K | -277K | -126K | -223K | -295K |
| Capital Expenditures | -19K | -143K | -97K | -55K | -151K | -682K | -277K | -126K | -223K | -295K |
| CapEx % of Revenue | 1.22% | 8.3% | 3.39% | 1.76% | 2.48% | 7.71% | 2.94% | 0.83% | 1.4% | - |
| Acquisitions | 0 | 101K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 1.02M | 0 | 0 | 0 | 55K | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 2.21M | 7.1M | 6.81M | 9.66M | 9.34M | 16.27M | -225K | 1.74M | -329K | 663K |
| Debt Issued (Net) | 785K | -682K | 3.67M | 1.58M | 409K | -209K | -365K | -503K | -407K | -597K |
| Equity Issued (Net) | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 129K | 1000K | 78K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -1K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -10K | 7.78M | 1.13M | 1.46M | 0 | 273K | 11K | 0 | 0 | 0 |
| Net Change in Cash | -334K▲ 0% | 370K▲ 210.8% | -40K▼ 110.8% | 467K▲ 1267.5% | 1.81M▲ 287.2% | 9.01M▲ 398.5% | -8.22M▼ 191.2% | -1.94M▲ 76.4% | -113K▲ 94.2% | 1.25M▲ 0% |
| Free Cash Flow | -3.57M▲ 0% | -6.83M▼ 91.5% | -6.85M▼ 0.3% | -9.2M▼ 34.2% | -7.58M▲ 17.5% | -7.26M▲ 4.3% | -8M▼ 10.2% | -3.69M▲ 53.9% | 216K▲ 105.9% | 589K▲ 0% |
| FCF Margin % | -229.22% | -396.58% | -239.21% | -294.08% | -124.51% | -82.03% | -84.98% | -24.25% | 1.35% | 2.74% |
| FCF Growth % | 71.63% | -91.45% | -0.26% | -34.23% | 17.52% | 4.3% | -10.18% | 53.93% | 105.86% | 345.42% |
| FCF per Share | -74254.13 | -441.86 | -95.08 | -32.29 | -9.21 | -6.88 | -7.03 | -2.84 | 0.15 | 0.15 |
| FCF Conversion (FCF/Net Income) | 0.47x | 0.32x | 0.43x | 0.69x | 0.70x | 0.77x | 0.63x | 0.61x | -0.10x | -0.47x |
| Interest Paid | 0 | 0 | 0 | 36K | 20K | 34K | 0 | 0 | 0 | 85K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PRPO Key Ratios
Precipio, Inc. (PRPO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | -158.88% | -163.92% | -137.03% | -77.65% | -44.11% | -59.57% | -38.01% | -32.35% | -9.12% |
| Return on Invested Capital (ROIC) | - | -512.82% | -77.2% | -67.14% | -51.36% | -52.7% | -66.93% | -40.31% | -24.32% | -24.32% |
| Gross Margin | -13.17% | 16.95% | 7.86% | 7% | 18.88% | 27.03% | 26.67% | 39.6% | 47.35% | 47.48% |
| Net Margin | -489.15% | -1201.04% | -547.97% | -423.5% | -174.41% | -96.62% | -129.65% | -38.51% | -26.87% | -5.83% |
| Debt / Equity | - | 0.27x | 0.83x | 0.10x | 0.11x | 0.06x | 0.09x | 0.08x | 0.10x | 0.10x |
| Interest Coverage | -15.09x | -6.67x | -8.71x | -23.24x | -19.46x | -480.65x | -1066.42x | -423.33x | -56.97x | -13.58x |
| FCF Conversion | 0.47x | 0.32x | 0.43x | 0.69x | 0.70x | 0.77x | 0.63x | 0.61x | -0.10x | -0.47x |
| Revenue Growth | -5.81% | 10.66% | 66.22% | 9.18% | 94.82% | 45.26% | 6.36% | 61.46% | 5.05% | 23.63% |
PRPO Frequently Asked Questions
Precipio, Inc. (PRPO) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Precipio, Inc. (PRPO) reported $21.5M in revenue for fiscal year 2024. This represents a 7% decrease from $23.0M in 1999.
Precipio, Inc. (PRPO) grew revenue by 5.1% over the past year. This is steady growth.
Precipio, Inc. (PRPO) reported a net loss of $1.3M for fiscal year 2024.
Dividend & Returns
Precipio, Inc. (PRPO) has a return on equity (ROE) of -32.3%. Negative ROE indicates the company is unprofitable.
Precipio, Inc. (PRPO) generated $0.6M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More PRPO
Precipio, Inc. (PRPO) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates